What This Document Is
This document represents lecture thirteen from the DRUG DISCOVERY & DEVELOPMENT (CHEM 474) course at the University of Illinois at Urbana-Champaign. It’s a focused exploration of biomarkers – measurable indicators used to assess biological states and processes – and their critical role within the broader landscape of pharmaceutical research and clinical diagnostics. The lecture delves into the characteristics of effective biomarkers and cautions against potential pitfalls in their interpretation.
Why This Document Matters
Students enrolled in drug discovery, pharmacology, medicinal chemistry, or related biomedical fields will find this material particularly valuable. It’s also beneficial for anyone seeking a deeper understanding of how biological measurements are used to evaluate health, disease, and the effectiveness of therapeutic interventions. This lecture serves as a foundational resource for understanding biomarker applications throughout the drug development pipeline and in personalized medicine. Accessing the full content will equip you with a framework for independent learning in this rapidly evolving field.
Topics Covered
* Defining biomarkers and their significance in biological systems
* The application of biomarkers in the drug discovery process
* Conventional safety biomarkers utilized in research and clinical settings
* Key biomarkers related to cardiovascular health and metabolic function
* Categorization of different biomarker types (extrinsic, intrinsic, etc.)
* The importance of understanding normal versus abnormal biomarker values
* Biomarkers as surrogate endpoints in clinical trials
What This Document Provides
* A comprehensive overview of the concept of biomarkers and their utility.
* Discussion of the physiological and biochemical principles underlying various biomarkers.
* References to external resources, including a video illustrating biomarker applications.
* A structured categorization of biomarker types to aid in understanding their diverse roles.
* A foundation for further exploration of specific biomarkers and their clinical relevance.
* Tables outlining examples of conventional safety biomarkers and their associated target tissues.
